NARI Stock Price, Chart, Stats & News

Inari Medical, Inc.
Save
4.68B
Market cap
–
Current P/E
–
Forward P/E
NARI chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 88.03% |
Operating margin | -2.84% |
Pretax margin | 0.86% |
Net margin | -0.33% |
Effective tax rate | 138.53% |
ROA | -0.24% |
ROE | -0.37% |
D/E | 0.07x |
Interest coverage ratio | -71.59x |
NARI valuation
P/E | – |
P/S | 9.49x |
P/B | 9.77x |
P/CF | 126.37x |
P/FCF | 157.55x |
P/OCF | 126.37x |
PEG | 73.50x |
EV multiple | 308.81x |
About
Inari Medical, Inc. is a medical technology firm focused on creating, producing, promoting, and distributing devices for the minimally invasive management of venous conditions within the United States. Their product portfolio includes ClotTriever, a mechanical thrombectomy solution designed to extract significant clots from major blood vessels, specifically targeting deep vein thrombosis. Another key offering is FlowTriever, a substantial catheter-based aspiration and mechanical thrombectomy system, which addresses pulmonary embolism.
Similar securities
Based on sector and market capitalization
Report issue











